Morgan E. Obrien - 16 Dec 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Reporting relationship: Executive Chairman, Director
Issuer ticker: ATEX
Reported as of: 16 Dec 2024
Net transaction value: -$455,085
SEC form: 4
Accepted by SEC: 17 Dec 2024, 16:28:37 UTC
Prior SEC filing: 11 Dec 2024
Source filing: View source filing
Reporting owner signature: s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Morgan E. Obrien filed Form 4 for Anterix Inc. (ATEX) on 17 Dec 2024.

Key facts

This page summarizes Morgan E. Obrien's Form 4 filing for Anterix Inc. (ATEX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Dec 2024, 16:28.

Change

Previous filing in this sequence was filed on 11 Dec 2024.
Current net transaction value: -$455,085.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Sale

Transaction value: $455,085
Shares: -13,609
Change %: -36%
Price: $33.44
Shares after: 23,973
Date: 16 Dec 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $33.34 to $33.55. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.